Laurus Labs reports 30% fall in Q4 consolidated net profit

25 Apr 2024 Evaluate

Laurus Labs has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 18.62% rise in its net profit at Rs 121.32 crore for the quarter under review as compared to Rs 102.28 crore for the same quarter in the previous year. Total income of the company increased by 11.93% at Rs 1,438.61 crore for Q4FY24 as compared Rs 1,285.28 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 29.77% fall in its net profit at Rs 75.32 crore for fourth quarter ended March 31, 2024 as compared to Rs 107.24 crore for the same quarter in the previous year. However, total income of the company increased by 5.47% at Rs 1,458.20 crore for Q4FY24 as compared Rs 1382.61 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 70.58% fall in its net profit at Rs 223.70 crore as compared to Rs 760.38 crore for the previous year. Total income of the company decreased by 16.06% at Rs 4,859.81 crore for year under review as compared to Rs 5,789.40 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 78.89% fall in its net profit at Rs 168.21 crore as compared to Rs 796.64 crore for the previous year. Total income of the company decreased by 16.20% at Rs 5,067.17 crore for year under review as compared to Rs 6,046.55 crore for year ended March 31, 2023. 


Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.